Hwang Jeong-Min, Chang Bong Leen, Koh Hyoung Jun, Kim Ji Yeon, Park Sung Sup
Department of Ophthalmology, Seoul Municipal Boramae Hospital, Seoul, Korea.
J Korean Med Sci. 2002 Apr;17(2):283-6. doi: 10.3346/jkms.2002.17.2.283.
Leber's hereditary optic neuropathy (LHON) is a maternally transmitted disease causing acute or subacute, bilateral optic atrophy mainly in young men. It is found to be a mitochondrial disorder with the primary mitochondrial DNA (mtDNA) mutations at 11,778, 3460, and 14,484. The incidence of each mutation is reported to be race-dependent. Point mutations at mtDNA nucleotide position 11,778 and 14,484 have been reported in Korean patients with LHON, however there has been no report of mtDNA mutation at nucleotide position 3460. Molecular genetic analyses at four primary sites (11,778, 14,484, 15,257, and 3460) of mitochondrial DNA using the polymerase chain reaction, restriction enzyme digestion, and direct sequencing were performed in a 35-yr-old man with severe visual loss. A point mutation in the mtDNA at nucleotide position 3460 was identified and a conversion of a single alanine to a threonine was confirmed. To our knowledge, this is the first report confirming mtDNA mutation at nucleotide position 3460 in Korean patients with LHON. Detailed molecular analyses would be very helpful for the correct diagnosis of optic neuropathy of unknown etiology and for genetic counseling.
莱伯遗传性视神经病变(LHON)是一种母系遗传疾病,主要导致年轻男性急性或亚急性双侧视神经萎缩。它是一种线粒体疾病,主要的线粒体DNA(mtDNA)突变发生在11778、3460和14484位点。据报道,每种突变的发生率与种族有关。韩国LHON患者中已报道了mtDNA核苷酸位置11778和14484的点突变,然而,尚未有关于核苷酸位置3460处mtDNA突变的报道。我们对一名35岁严重视力丧失的男性患者,使用聚合酶链反应、限制性内切酶消化和直接测序技术,对线粒体DNA的四个主要位点(11778、14484、15257和3460)进行了分子遗传学分析。在核苷酸位置3460处发现了mtDNA的点突变,并证实了单个丙氨酸向苏氨酸的转换。据我们所知,这是首次在韩国LHON患者中证实核苷酸位置3460处的mtDNA突变。详细的分子分析对于正确诊断病因不明的视神经病变和遗传咨询将非常有帮助。